Markets › India › NSE › ALIVUS

Alivus Life Sciences Ltd

NSE:ALIVUSHealthcare

₹1,268.60−3.12%At closeAt close · Mon 19 Oct · ≈ AED 49.01 · Market cap $1.69B · Next earnings Thu 5 Nov

INR billions	FY2021	FY2022	FY2023	FY2024	FY2024	FY2025	YoY
Net income	4.7	5.6	6.3	6.3	6.5	5.6	−13.7%
Depreciation & amortization	0.3	0.4	0.4	0.5	0.6	0.8	+24.3%
Stock-based compensation	0.0	0.0	0.0	0.0	0.0	0.0	—
Change in working capital	(1.1)	1.0	(2.0)	(1.3)	(1.8)	(1.3)	+28.7%
Operating cash flow	3.9	6.0	3.1	4.1	4.1	5.7	+37.6%
Capital expenditure	(0.7)	(1.3)	(1.6)	(1.3)	(1.7)	(3.1)	−84.8%
Acquisitions	0.0	0.0	0.0	0.0	0.0	0.0	+2.9%
Investing cash flow	(0.7)	(1.2)	(1.5)	(1.2)	(6.4)	(5.7)	+10.2%
Dividends paid	0.0	(1.3)	(3.9)	(2.8)	0.0	(0.6)	—
Share buybacks	0.0	0.0	0.0	0.0	0.0	0.0	—
Debt issued / repaid	(2.1)	(9.6)	0.0	(0.0)	0.0	0.0	—
Financing cash flow	(2.1)	(0.8)	(3.9)	(2.8)	(0.1)	(0.6)	−949.0%
Free cash flow	3.2	4.7	1.4	2.8	2.5	2.6	+5.7%
Net change in cash	1.1	4.0	(2.3)	0.2	(2.3)	(0.7)	+70.0%

INR billionsUpdated Tue 31 Mar ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.